Bioactive Compounds from Medicinal Plants for Cancer Therapy and Chemoprevention -  - E-Book

Bioactive Compounds from Medicinal Plants for Cancer Therapy and Chemoprevention E-Book

0,0
34,94 €

-100%
Sammeln Sie Punkte in unserem Gutscheinprogramm und kaufen Sie E-Books und Hörbücher mit bis zu 100% Rabatt.
Mehr erfahren.
Beschreibung

This book aims to fill research gaps in the search for chemotherapeutic and chemopreventive natural compounds. It includes a collection of detailed reviews focusing on bioactive compounds from plant sources that can be beneficial for cancer therapy. Topics covered include the role of antioxidants in cancer therapy, medicinal plants for cancer chemotherapeutics, bioactive compounds from marine plants, and a review of inhibiting nitric oxide reactions for preventing cancer. Chapters are contributed by researchers who have provided detailed lists and descriptions of the relevant plant sources, the compounds and the biochemical reactions. The book includes references for advanced reading. This book is intended as a reference for scholars and healthcare professionals studying natural medicines for cancer prevention and treatment.

Readership
Scholars in the field of medicinal chemistry, pharmacology and herbal medicine.

Das E-Book können Sie in Legimi-Apps oder einer beliebigen App lesen, die das folgende Format unterstützen:

EPUB
MOBI

Seitenzahl: 293

Veröffentlichungsjahr: 2024

Bewertungen
0,0
0
0
0
0
0
Mehr Informationen
Mehr Informationen
Legimi prüft nicht, ob Rezensionen von Nutzern stammen, die den betreffenden Titel tatsächlich gekauft oder gelesen/gehört haben. Wir entfernen aber gefälschte Rezensionen.



Table of Contents
BENTHAM SCIENCE PUBLISHERS LTD.
End User License Agreement (for non-institutional, personal use)
Usage Rules:
Disclaimer:
Limitation of Liability:
General:
PREFACE
List of Contributors
Role of Antioxidants in Cancer Therapy and Chemoprevention
Abstract
INTRODUCTION
ANTIOXIDANTS AND TREATMENTS IN CANCER THERAPY
MECHANISM BEHIND ANTIOXIDANTS FOR CHEMOPREVENTION
MOLECULAR REACTION OF NATURAL COMPOUNDS FOR CHEMOPREVENTION
SKELETON MECHANISM FOR CHEMOPREVENTION
ANTIOXIDANTS IN CANCER THERAPY
CONCLUSION
REFERENCES
Medicinal Plants and Cancer Chemoprevention
Abstract
INTRODUCTION
TYPES OF TREATMENT FOLLOWED FOR CANCER
ADVERSE EFFECTS OF CANCER TREATMENTS
ADVANTAGES OF HERBAL DRUGS OVER ALLOPATHIC DRUGS IN CHEMOPREVENTION
PLANTS WITH TREMENDOUS ANTICANCER ACTIVITIES
Catharanthus Roseus
Camptotheca Acuminata
Annona Muricata L.
Tinospora Cordifolia
Withania Somnifera
Rumex Acetosella
CONCLUSION
ACKNOWLEDGEMENTS
REFERENCES
Bioactive Compounds Derived from Marine Sources for Cancer Therapy and Chemoprevention
Abstract
INTRODUCTION
MECHANISM OF ANTICANCER ACTION
MARINE-BASED ANTICANCER DRUGS
MARINE-BASED ANTICANCER DRUGS IN CLINICAL AND PRECLINICAL TRIALS
CHEMOPREVENTION VIA NUTRACEUTICALS
CONCLUSION/SUMMARY AND FUTURE PROSPECTS
ACKNOWLEDGEMENTS
References
Bioactive Compounds in Cancer Therapy and Chemoprevention
Abstract
INTRODUCTION
CONVENTIONAL STRATEGIES OF CANCER THERAPY: CURRENT STATUS AND LIMITATIONS
Chemotherapy and Chemoresistance
CHEMOPREVENTION AND CHEMOSENSITIZATION APPROACHES IN CANCER THERAPY
PLANT-DERIVED BIOACTIVE COMPOUNDS AS NOVEL ANTI-CANCER AGENTS
Curcumin
Resveratrol
Uttroside B
Kaempferol
Tryptanthrin
Cucurbitacin B
Gingerol
Emodin
Quercetin
Genistein
Lycopene
Epigallocatechin Gallate
Piperine
Berberine
Apigenin
Luteolin
Indirubin
Silibinin
CONCLUSION AND FUTURE PERSPECTIVES
AUTHOR CONTRIBUTIONS
ACKNOWLEDGEMENTS
REFERENCES
Antioxidant-Oxidative Stress Balance in Chemoprevention of Cancer
Abstract
Introduction
Cancer and Oxidative Stress
Sources of Oxidative Stress in the Body
Effects of Oxidative Damage at Cellular Level
Antioxidants
Cancer Therapy and Chemoprevention
Role of Antioxidants in Cancer Therapy and Chemoprevention
Conclusion
References
Inhibition of Nitric Oxide and Free Radical Production by Leaf and Stem Extracts of Psychotria nilgiriensis
Abstract
INTRODUCTION
MATERIALS AND METHODS
Chemicals
Collection and Identification of Plant Materials
Preparation of Crude Extracts using Solvents from Plant Materials
Antioxidant Assays
DPPH Radical Scavenging Activity
Total Antioxidant Capacity
Determination of Oxygen Radical Antioxidant Capacity (ORAC)
Assay for Measurement of Nitric Oxide (Nitrite Assay)
Cell Culture
Measurement of Nitric Oxide (Nitrite Assay)
Cell Viability Assay
LC-MS Data Acquisition and Analysis
Statistical Analysis
RESULTS AND DISCUSSION
Extractability of Polyphenolics
Antioxidant Activity
Free Radical Scavenging Activity Against DPPH·
Total Antioxidant Capacity
Oxygen Radical Scavenging Capacity
Cell Viability Activity
Sample Metabolite Profiling
Identification of Compounds from Plant Extracts
Conclusion
ACKNOWLEDGEMENTS
REFERENCES
Plant-Derived Compounds for Chemoprevention and Chemotherapy: From Molecular Mechanisms to Clinical Trials
Abstract
INTRODUCTION
SIGNIFICANCE OF NATURAL COMPOUNDS FOR CANCER THERAPY AND CHEMOPREVENTION
CHEMICAL COMPOSITION
MECHANISM OF ACTION OF NATURAL PRODUCTS FOR MOLECULAR TARGETS
CLINICAL STUDIES OF IMPORTANT ANTICANCER PLANT BASED NATURAL PRODUCTS
in vitro STUDIES OF BENEFICIAL PLANT-DERIVED ANTICANCER COMPOUNDS
CHALLENGES IN THE DISCOVERY OF CHEMOPREVENTIVE DRUGS OBTAINED FROM PLANT-DERIVED COMPOUNDS
CONCLUSION AND FUTURE PERSPECTIVES
LIST OF ABBREVIATIONS
ACKNOWLEDGEMENTS
REFERENCES
Medicinal Plants and Cancer Therapy and Chemoprevention
Abstract
INTRODUCTION
Medicinal Plants
Cancer Therapy
Chemoprevention
Selected Medicinal Plants for Cancer Prevention and Therapy
CONCLUSION
ACKNOWLEDGEMENTS
REFERENCES
Bioactive Compounds from
Medicinal Plants for Cancer
Therapy and Chemoprevention
Edited by
Blassan George
University of Johannesburg
Laser Research Centre / Faculty of Health Sciences
South Africa

BENTHAM SCIENCE PUBLISHERS LTD.

End User License Agreement (for non-institutional, personal use)

This is an agreement between you and Bentham Science Publishers Ltd. Please read this License Agreement carefully before using the book/echapter/ejournal (“Work”). Your use of the Work constitutes your agreement to the terms and conditions set forth in this License Agreement. If you do not agree to these terms and conditions then you should not use the Work.

Bentham Science Publishers agrees to grant you a non-exclusive, non-transferable limited license to use the Work subject to and in accordance with the following terms and conditions. This License Agreement is for non-library, personal use only. For a library / institutional / multi user license in respect of the Work, please contact: [email protected].

Usage Rules:

All rights reserved: The Work is the subject of copyright and Bentham Science Publishers either owns the Work (and the copyright in it) or is licensed to distribute the Work. You shall not copy, reproduce, modify, remove, delete, augment, add to, publish, transmit, sell, resell, create derivative works from, or in any way exploit the Work or make the Work available for others to do any of the same, in any form or by any means, in whole or in part, in each case without the prior written permission of Bentham Science Publishers, unless stated otherwise in this License Agreement.You may download a copy of the Work on one occasion to one personal computer (including tablet, laptop, desktop, or other such devices). You may make one back-up copy of the Work to avoid losing it.The unauthorised use or distribution of copyrighted or other proprietary content is illegal and could subject you to liability for substantial money damages. You will be liable for any damage resulting from your misuse of the Work or any violation of this License Agreement, including any infringement by you of copyrights or proprietary rights.

Disclaimer:

Bentham Science Publishers does not guarantee that the information in the Work is error-free, or warrant that it will meet your requirements or that access to the Work will be uninterrupted or error-free. The Work is provided "as is" without warranty of any kind, either express or implied or statutory, including, without limitation, implied warranties of merchantability and fitness for a particular purpose. The entire risk as to the results and performance of the Work is assumed by you. No responsibility is assumed by Bentham Science Publishers, its staff, editors and/or authors for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products instruction, advertisements or ideas contained in the Work.

Limitation of Liability:

In no event will Bentham Science Publishers, its staff, editors and/or authors, be liable for any damages, including, without limitation, special, incidental and/or consequential damages and/or damages for lost data and/or profits arising out of (whether directly or indirectly) the use or inability to use the Work. The entire liability of Bentham Science Publishers shall be limited to the amount actually paid by you for the Work.

General:

Any dispute or claim arising out of or in connection with this License Agreement or the Work (including non-contractual disputes or claims) will be governed by and construed in accordance with the laws of Singapore. Each party agrees that the courts of the state of Singapore shall have exclusive jurisdiction to settle any dispute or claim arising out of or in connection with this License Agreement or the Work (including non-contractual disputes or claims).Your rights under this License Agreement will automatically terminate without notice and without the need for a court order if at any point you breach any terms of this License Agreement. In no event will any delay or failure by Bentham Science Publishers in enforcing your compliance with this License Agreement constitute a waiver of any of its rights.You acknowledge that you have read this License Agreement, and agree to be bound by its terms and conditions. To the extent that any other terms and conditions presented on any website of Bentham Science Publishers conflict with, or are inconsistent with, the terms and conditions set out in this License Agreement, you acknowledge that the terms and conditions set out in this License Agreement shall prevail.

Bentham Science Publishers Pte. Ltd. 80 Robinson Road #02-00 Singapore 068898 Singapore Email: [email protected]

PREFACE

Research on medicinal plants is one of the most important areas in oncology with high potential in the design and development of cost-effective drugs. Natural products in the treatment of diseases have been practiced since ancient times. Cancer chemoprevention is a broad term that uses synthetic and natural compounds to slow down, suppress or reverse carcinogenesis. The onset of cancer depends on various factors such as intrinsic and extrinsic. Natural therapies, such as the use of plant-derived products and medicinal plant extracts in cancer treatment, may reduce the adverse side effects of conventional treatments. The cancer control measures are related to the origin and risk factors. Every cancer type needs specialized therapy, and the most important treatment goal is to eradicate tumour and prolong the patients’ lifespan. Alternative therapies have been playing a crucial role in cancer treatment and management. Several studies reported that medicinal plants and bioactive compounds from plants can work well as an alternative cancer treatment option for different types of cancers due to fewer side effects and cost-effectiveness compared to many existing treatments. Phytochemicals from medicinal plants were reported to reduce various risk factors associated with cancer through their chemopreventive action. This book highlights the role of bioactive compounds and dietary factors or natural products from plants or medicinal plant extracts in the chemoprevention of various types of cancer. Since the role of antioxidants in chemoprevention is unavoidable, an insight into plant-based antioxidant compounds that fight against cancer is also discussed in this book. Medicinal plants, bioactive compounds derived from marine sources, and the role of antioxidants in cancer therapy and chemoprevention, and molecular mechanisms in clinical trials are included in this book. This will fill the research gap in search of chemopreventive natural compounds and encourage researchers to produce anticancer agents from plants in clinical trials.

Blassan George University of Johannesburg Laser Research Centre / Faculty of Health Sciences South Africa

List of Contributors

Arunaksharan NarayanankuttyDivision of Cell and Molecular Biology, PG & Research Department of Zoology, St. Joseph’s College (Autonomous), Devagiri, Calicut, Kerala, IndiaAparna PrasadPhytochemistry and Pharmacology Division, PG & Research Department of Botany, St. Joseph’s College (Autonomous), Devagiri, Calicut, Kerala, IndiaBlassan GeorgeFaculty of Health Sciences, University of Johannesburg Laser Research Centre, Johannesburg, South AfricaChenicheri Kizhakkeveettil KeerthanaDivision of Cancer Research, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, 695014, Kerala, India Department of Biotechnology, University of Kerala, Thiruvananthapuram,695011, Kerala, IndiaEun-Jung ParkThe Daniel K. Inouye College of Pharmacy, University of Hawaii at Hilo, Hilo, Hawaii 96720, USAG. RajapandeeswariKarpagam Academy of Higher Education, Pollachi Main Road, Coimbatore-641021, IndiaGiriraj KalaiarasiDepartment of Chemistry, Karpagam Academy of Higher Education, Coimbatore-21, Tamil Nadu, India Centre for Material Chemistry, Karpagam Academy of Higher Education, Coimbatore-21, Tamil Nadu, IndiaJameema SidhicPhytochemistry and Pharmacology Division, PG & Research Department of Botany, St. Joseph’s College (Autonomous), Devagiri, Calicut, Kerala, IndiaJ. JothikaKarpagam Academy of Higher Education, Pollachi Main Road, Coimbatore-641021, IndiaJ. Mohana PriyaKarpagam Academy of Higher Education, Pollachi Main Road, Coimbatore-641021, IndiaK. NirubamaKongunadu Arts and Science College, Coimbatore-641029, Tamil Nadu, IndiaM. KalaimathiKarpagam Academy of Higher Education, Pollachi Main Road, Coimbatore-641021, IndiaMurugan RajanCentre for Research and Postgraduate Studies in Botany, Ayya Nadar Janaki Ammal College (Autonomous), Sivakasi, 626 124, Tamil Nadu, IndiaNiharika SharmaDepartment of Life Science, Shri Vaishnav Institute of Science, Shri Vaishnav Vidyapeeth Vishwavidyalaya, Indore 453111, Madhya Pradesh, IndiaP. RevathiKongunadu Arts and Science College, Coimbatore-641029, Tamil Nadu, IndiaParimelazhagan ThangarajBioprospecting Laboratory, Department of Botany, Bharathiar University, Coimbatore 641 046, India The Daniel K. Inouye College of Pharmacy, University of Hawaii at Hilo, Hilo, Hawaii 96720, USAPezzuto M. JohnThe Daniel K. Inouye College of Pharmacy, University of Hawaii at Hilo, Hilo, Hawaii 96720, USARuby John AntoDivision of Cancer Research, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, 695014, Kerala, IndiaRamasamy IndumathyDepartment of Chemistry, Nallamuthu Gounder Mahalingam College, Affiliated to Bharathiar University, Coimbatore-01, Tamil Nadu, IndiaSreekumar Usha Devi AiswaryaDivision of Cancer Research, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, 695014, Kerala, IndiaSadiq Chembothumparambil ShifanaDivision of Cancer Research, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, 695014, Kerala, IndiaSatheesh GeorgePhytochemistry and Pharmacology Division, PG & Research Department of Botany, St. Joseph’s College (Autonomous), Devagiri, Calicut, Kerala, IndiaSandhya VermaDepartment of Life Science, Shri Vaishnav Institute of Science, Shri Vaishnav Vidyapeeth Vishwavidyalaya, Indore 452001, Madhya Pradesh, IndiaSimeon O. KotchoniCenter for Computational and Integrative Biology, Rutgers University, 315 Penn St., Camden, NJ 08102, USAS. ParveenDepartment of Chemistry, Dr. Mahalingam College of Engineering and Technology, Pollachi-03, Tamil Nadu, IndiaT. Sathiya KamatchiDepartment of Chemistry, Bharathidasan University, Tiruchirapalli-24, Tamil Nadu, IndiaTamara P. KondratyukThe Daniel K. Inouye College of Pharmacy, University of Hawaii at Hilo, Hilo, Hawaii 96720, USATennyson Prakash RayginiaDivision of Cancer Research, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, 695014, Kerala, India Department of Biotechnology, University of Kerala, Thiruvananthapuram,695011, Kerala, IndiaVandana VarmaDepartment of Microbiology, Mahatma Gandhi Memorial Medical College, Indore 452001, Madhya Pradesh, India

Role of Antioxidants in Cancer Therapy and Chemoprevention

P. Revathi1,*,K. Nirubama1
1 Kongunadu Arts and Science College, Coimbatore-641029, Tamil Nadu, India

Abstract

Malignant diseases have been highlighted as one of the most prominent causes of human mortality worldwide. The prevalence of cancer is constantly increasing and is expected to reach three-fourths of the population in the next two decades. Conventional cancer treatment involves surgery, controlling and reducing the growth of cancer tissues using radiation, and chemotherapy. Many incidences prove that chemical treatment for cancer is immensely associated with the recurrence of cancer, and the development of resistance, and is prone to severe side effects. Since natural products have now been used in the treatment of various diseases, the anticancer properties of natural drugs and druggable products are interceded by various mechanisms, including the initiation of programmed cell death, modulations in the immune system, and inhibition of angiogenesis. Edible, medicinal plants and spices used in traditional medicine to regulate vital molecular targets are important chemo-preventive agents in the treatment of chemo and radiation therapy-induced toxicities in drug development. Natural agents could trigger cell death signalling pathways in tumour cells by stimulating anti-apoptotic proteins and/or overcoming pro-apoptotic proteins and caspases. It inhibit protein kinase B (Akt), phosphatidylinositide 3-kinases (PI3K), epidermal growth factor receptor/mitogen-activated protein kinase (EGFR/MAPK), as well as nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB). Bax/Bcl-2 ratio changes, inhibiting cellular proliferation, and differentiation, and also activating apoptosis lead to less prominence. To summarize, this chapter highlights the current status, and forthcoming prospects of cancer treatment and prevention as well as the potential of bioactive compounds that have been used in cancer treatment and chemoprevention.

Keywords: Antioxidants, Bioactive compounds, Free radicals, Molecular targets and chemoprevention.
*Corresponding author P. Revathi: Kongunadu Arts and Science College, Coimbatore-641029, Tamil Nadu, India; E-mail: [email protected]

INTRODUCTION

Cancer is a life-threatening disease and a prominent cause of death globally [1], and is probable to rise in the next 2 decades. Generally, it is assessed that the total

cancer prevalence could extend up to 2.84 crore in 2040 [2]. Oxidative stress induced by free radicals is usually found in physiological and metabolic processes and the human body has a defensive system of antioxidant mechanisms; these include enzymatic antioxidants e.g., superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPX) as well as natural antioxidants such as vitamins, carotenoids, polyphenols, and other antioxidants, which have the potential to neutralize free radicals [3]. Henceforth, research has been directed towards therapeutic plants and the promising potential of such plants in various traditional and alternative medicine systems for use in humans has been valued. The secondary metabolites are measured as good chemopreventive agents and can be used for cancer therapy due to the high concentration and a wide variety of natural antioxidants such as resveratrol, vitamins, flavonoids, polyphenols, and other compounds found to influence different cancer cells both in vitro and in vivo. As an antioxidant network, these natural antioxidants also have efficient synergistic interactions and renewing prospects [4]. Though huge advances have been made in research focusing on the etiology and molecular substructures of cancer, the treatment for cancer has severe side effects that limit patients’ quality of life.

Hence, it is a matter of life and death to intend processes to diminish cancer occurrence or inhibit the development of cancer to its advanced stage. The knowledge of chemical prevention is acquired with more concern comparatively due to its success in reducing the frequency of metabolic disorders and heart diseases.

Chemo preventives can be classified based on the point at which they perform as primary, secondary, and tertiary groups. Primary chemopreventive are aimed at suppressing the incidence of cancer formation in a predisposed metabolism. Secondary chemical prevention agents overwhelm the evolution of cancer prevalence from non-dangerous (benign) to dangerous (malignant). Tertiary chemical prevention agents lower the risk of tumour reappearance following a suitable treatment like incision and/or chemotherapy [2]. Among several kinds of cancer chemo preventive agents, hormonal and vaccines are recorded as more promising means for future research and therapeutics. In addition, individuals who have benefitted from chemical prevention due to their hereditary advantages give diverse interpretations for the efficient assessment of cancer chemotherapy [5].

ANTIOXIDANTS AND TREATMENTS IN CANCER THERAPY

The metabolic trembling molecules acknowledged as free radicals have damaged the other molecules. In presence of oxidative stress, these free radicals develop cancer and a chain of reactive oxygen species. Antioxidants play a vital role in plants' and animals’ nutrition because they react with these free radicals, which soothe and quench them. Natural antioxidants from plants including vitamins C, E, and A, curcumin, beta-carotene, kaempferol, and quercetin assure that the systematic intake of fruits and vegetables has consistently reduced not only the risk of cancer incidence but also other diseases like Cardiovascular disease, Diabetes, Alzheimer's disease, etc. [6].

In recent years, neoplasm medicine research has taken significant steps towards additional efficiency, specifically invasive cancer treatments. Nanomedicine combined with directed treatment aided in recovering the bio-distribution of novel or existing chemotherapeutic agents. Other approaches like gene therapy, siRNA delivery, immunotherapy, and antioxidant supplements provide new prospects for malignancy victims. In contrast, hyperthermal or hypothermal treatments are favourable substitutes and personalised medicine for tumour excision. Additionally, recent radiomics and pathomics methods for the management of big data sets from cancer patients to recover and predict cancer recurrence and related effects on their health [7].

Most of the novel therapies, including nanomedicine are flexible and safe for the living tissues and environment and can deliver chemotherapeutic drugs that can also be used with diverse applications from diagnosis to treatment [8]. Extracellular vesicles play a significant role in apoptosis and are explored as a proficient remedy in cancer therapy. Plant-derived antioxidants and numerous bioactive compounds have been recently used as adjuvant cancer treatments with pro-apoptotic properties. Gene therapy targets genes that trigger cancer suppressors and tumor suppressors that have been valued and tested in many clinical trials worldwide [9]. These approaches are the best-adapted treatments for cancer sufferers and the prominence of multi-disciplinary approaches to attain the desirable effects as proved in various clinical experiments. Cancer treatments and newly anticipated approaches that are in the investigation phase should overcome the constraints of cancer. Diverse strategies for cancer diagnosis, treatment and addressing existing consequences from the scientific perspectives and causal impacts of natural agents are required to approach the disease closer [10]. Though much debate has arisen about the efficiency of cancer chemotherapy, inadequate substantiation has been observed in both the quality and dose of antioxidants, which suggests that they may reduce antagonistic responses and harmfulness [11]. It is indicated that researchers’ effort to explore alternate composition and treatment methods to reduce persistence, growth and multiplication, transference of cancer cells, and development of blood vessels [12] and the interface of chemical treatment and antioxidants is more complicated than merely preventing oxidative stress. However, there are numerous multifaceted mechanisms in the metabolic process, which is an acceptable truth.

Each antioxidant has diverse role in chemotherapy and these influences can be adjusted based on the dose. In research on the role of antioxidants in cancer therapy, two doses of antioxidants are used as preventive dose (low dose) and therapeutic dose (high dose). Evidently, many research outputs imply that low doses of antioxidants guard normal cells and avoid tumor prevalence, whereas high doses halt the growth of cancer cells but not normal cells [13]. Certain recent reviews on natural agents concluded that antioxidants, when given simultaneously with cancer therapy denied to interact with chemical drugs at treatment; furthermore, they increase the chemical drug efficiency and body’s reaction to the drug, act as a shield for unaffected cells, and increase the patient’s quality of life [14, 15].

MECHANISM BEHIND ANTIOXIDANTS FOR CHEMOPREVENTION

According to food composition data, we consume considerable amounts of anthocyanins, including delphinidin and malvidin, which can be obtained from fruits and vegetables. These anthocyanins are aglycones with a polyphenolic ring structure [16].

The consequences of reactive nitrogen species (RNS) and reactive oxygen species (ROS) leads to impairment in the cellular membrane and interfering biomolecules like amino acids and DNA; by this means, stimulating sequences of reactions are the sources of gene mutations and abnormal gene/protein expressions. Cancer stimulation or development, also known as carcinogenesis, is one of the processes that relate metabolism to various other factors [17]. This view emphasizes that scientific cancer research focuses on the concept of nutritional facilitation in order to prevent and suppress any efficient molecular target. The natural compounds from plant sources obstruct cancer stimulation by either of the predicted pathways.

According to Wattenberg in 1985, all kinds of chemopreventive agents are either inhibitors of carcinogen development, blocking or suppressing agents, or combinations of the above two or more. The agents may prevent cancer-triggering substance formation from the precursors or avoid mutations by hindering particular metabolic pathways or purification methods by scavenging ROS. Ultimately, it prevents cancer cell proliferation through apoptosis, autophagy, and necrosis stimulation [18].

MOLECULAR REACTION OF NATURAL COMPOUNDS FOR CHEMOPREVENTION

As a boon of nature, natural antioxidants like flavonoids, alkaloids, and phenolic acids may trigger pathways in cancer cells to death by playing more than one role in the course of free radical balance, antioxidants in normal cells, triggering apoptosis in cancer cells, activating and suppressing anti-apoptotic protein, pro-apoptotic protein and down-regulating pro-inflammatory signalling pathways. These antioxidants suppress cancer cell proliferation by inhibiting protein kinases of cellular metabolism [19-21].

After absorption, natural compounds undergo assimilation and chemical transformations like methylation, sulfation, or glucuronidation before they get into the bloodstream where they interact with the tissues. Natural chemical residues in the proximal intestine are digested further by microbes in the colon where microbial enzymes break down the complex heterocyclic ring into hydroxylated phenyl carboxylic acids. This simple form of chemical could be absorbed in the gastrointestinal tract in succeeding phases (Fig. 1) [22].

Fig. (1)) Natural compounds (Flavonoids) targets apoptosis pathway [22].

SKELETON MECHANISM FOR CHEMOPREVENTION

Natural agents could accelerate estrogen receptor-α (ER-α) expression and change two cytoplasmic proteins, B-cell lymphoma protein 2 (Bcl-2)-associated X (Bax) and Bcl-2 ratio which control the proliferation of cancer cells followed by differentiation and also prompting a programmed cell death process in cancer cells [23]. Condition of suppressed Bcl-2, Bcl-xL protein family controls cell death by the effects of C-inhibitor of apoptosis protein 1 (c-IAP1), survivin protein, and NF-κB in ovarian cancer cell lines (C200 and A2780) [24]. An amplified caspase-3 activity [25] and stimulated the intrinsic apoptotic signalling pathway led to the activation of caspases 7 and 9 and also changed the ratio of Bax/Bcl-2. Induction and reduction of anti-apoptotic protein expressions, resulting in mitochondrial cytochrome C release cause further stimulation and follow the apoptotic pathway linking caspases 3 and 9 [26].

Similarly, p53 protein stimulation by overexpression of oncogenes, heat shock, DNA damage, and hypoxia. Due to its function in cell fate results after stimulation, directing pathways aid in sustaining genome stability and thus providing shelter to the DNA against mutations that cause cancer [27]. Experiments proved to induce cell death via improved p53 expression, Bak, Bax, and caspase-3 cleaving, and reduced Bcl-2 expressions [28, 29].

Though, caspases are either initiators or effectors in the apoptosis process, all caspases are structurally similar [30]. The second mitochondrial activator of caspases (SMAC) endorses caspase stimulation in the cytochrome C/APAF-1/caspase-9 pathway. Here, SMAC clings to inhibitors of apoptosis proteins (IAPs), which stimulate caspase-9 activation and terminate their inhibitory activity [31].

Thus, novel natural drugs with rich antioxidant capability could target death receptor (DR)-mediated (extrinsic) and mitochondrial-mediated (intrinsic) pathways in metabolism which downregulate PI3K, Akt, and Bcl-2, BCL-xL proteins led to apoptosis in the cell cycle [32, 33].

ANTIOXIDANTS IN CANCER THERAPY

The efficiency of cancer therapeutic medications is successful but mostly limited to numerous harmful side effects. Hence, to reduce these side effects, antioxidant supplementation is frequently required to minimize ROS levels and harm. Thus, antioxidant supplementation could lessen side effects and inhibit the growth of cancer cells whereas shielding normal cells with a mixture of antioxidants along with chemotherapeutics delays further cancer development, checks chemo-resistance by refining the response to chemotherapy drugs, and improves cancer patients’ quality of life. Preclinical and clinical studies explored the efficacy of phytochemical and dietary antioxidants from different sources in the treatment of chemo and radiation therapy-induced toxicities and for the enhancement of cancer management efficacy. Besides higher taxonomic plant compounds, algae (both micro and macro) can be considered as alternative natural sources of antioxidants. Though there is enough knowledge on nutritional sources and benefits, the exploration and consumption of antioxidants, dosage, and limitations are still in their initial stages [34].

CONCLUSION

Cancer chemoprevention has been used as one or more pharmacologically dynamic agents that are proficient in blocking, suppressing, preventing, or reversing the development of invasive cancer. Exploitation of the chemical diversity of natural compounds may enrich the adept amalgams for cancer chemotherapy and chemoprevention. The new approaches and distinct clinical trials are indispensable and necessary be directed toward achieving nontoxic and effective antioxidant supplement coordination in cancer treatment. Similarly, more focused and broad research is needed to explore alternate antioxidant molecules from different sources and their extraction, purification procedures and examinations of animal metabolism are to be highlighted. Considering the several unprocessed organic and aqueous extracts with tremendous antioxidant ability along with biological properties that also have anticancer effects, scrutinizing their mechanisms of action in metabolism and their competence to potentiate chemotherapeutic drugs is a need of the hour.

REFERENCES

[1]Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021; 71(3): 209-49.[http://dx.doi.org/10.3322/caac.21660] [PMID: 33538338][2]G MS, Swetha M, Keerthana CK, Rayginia TP, Anto RJ. Cancer Chemoprevention: A Strategic Approach Using Phytochemicals. Front Pharmacol 2022; 12: 809308.[http://dx.doi.org/10.3389/fphar.2021.809308] [PMID: 35095521][3]Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006; 160(1): 1-40.[http://dx.doi.org/10.1016/j.cbi.2005.12.009] [PMID: 16430879][4]Seca A, Pinto D. Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application. Int J Mol Sci 2018; 19(1): 263.[http://dx.doi.org/10.3390/ijms19010263] [PMID: 29337925][5]Benetou V, Lagiou A, Lagiou P. Chemoprevention of cancer: current evidence and future prospects. F1000Res. 2015.[http://dx.doi.org/10.12688/f1000research.6684.1][6]Parasuraman S, Anand David AV, Arulmoli R. Overviews of biological importance of quercetin: A bioactive flavonoid. Pharmacogn Rev 2016; 10(20): 84-9.[http://dx.doi.org/10.4103/0973-7847.194044] [PMID: 28082789][7]Aerts HJWL, Velazquez ER, Leijenaar RTH, et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 2014; 5(1): 4006.[http://dx.doi.org/10.1038/ncomms5006] [PMID: 24892406][8]Yan L, Shen J, Wang J, Yang X, Dong S, Lu S. Nanoparticle-Based Drug Delivery System: A Patient-Friendly Chemotherapy for Oncology. Dose Response 2020; 18(3). [http://dx.doi.org/10.1177/1559325820936161] [PMID: 32699536][9]Bahreyni A, Luo H. Advances in Targeting Cancer-Associated Genes by Designed siRNA in Prostate Cancer. Cancers (Basel) 2020; 12(12): 3619.[http://dx.doi.org/10.3390/cancers12123619] [PMID: 33287240][10]Pucci C, Martinelli C, Ciofani G. Innovative approaches for cancer treatment: current perspectives and new challenges. Ecancermedicalscience 2019; 13: 961.[http://dx.doi.org/10.3332/ecancer.2019.961] [PMID: 31537986][11]Fuchs-Tarlovsky V. Role of antioxidants in cancer therapy. Nutrition 2013; 29(1): 15-21.[http://dx.doi.org/10.1016/j.nut.2012.02.014] [PMID: 22784609][12]Elham H, Ali H, Faroogh M, Mohammad RA, Saeed S. Anti-Cancer Agents in Medicinal Chemistry, (Formerly Current Medicinal Chemistry - Anti-Cancer Agents). Bentham Science Publishers 2020; 20(12): 398.[13]Singh K, Bhori M, Kasu YA, Bhat G, Marar T. Antioxidants as precision weapons in war against cancer chemotherapy induced toxicity – Exploring the armoury of obscurity. Saudi Pharm J 2018; 26(2): 177-90.[http://dx.doi.org/10.1016/j.jsps.2017.12.013] [PMID: 30166914][14]Tan BL, Norhaizan ME, Liew WPP, Sulaiman Rahman H. Antioxidant and Oxidative Stress: A Mutual Interplay in Age-Related Diseases. Front Pharmacol 2018; 9: 1162.[http://dx.doi.org/10.3389/fphar.2018.01162] [PMID: 30405405][15]Francenia Santos-Sánchez N, Salas-Coronado R, Villanueva-Cañongo C, Hernández-Carlos B. Antioxidant Compounds and Their Antioxidant Mechanism Internet2019.[http://dx.doi.org/10.5772/intechopen.85270][16]Yar Khan H, Zubair H, Fahad Ullah M, Ahmad A, Mumtaz Hadi S. A prooxidant mechanism for the anticancer and chemopreventive properties of plant polyphenols. Curr Drug Targets 2012; 13(14): 1738-49.[http://dx.doi.org/10.2174/138945012804545560] [PMID: 23140285][17]Adewumi Akanji M, Demilade Fatinukun H, Emmanuel Rotimi D, Lawrence Afolabi B, Stephen Adeyemi O. The Two Sides of Dietary Antioxidants in Cancer Therapy Internet2021.[http://dx.doi.org/10.5772/intechopen.94988][18]George BP, Chandran R, Abrahamse H. Role of Phytochemicals in Cancer Chemoprevention: Insights. Antioxidants 2021; 10(9): 1455.[http://dx.doi.org/10.3390/antiox10091455] [PMID: 34573087][19]Rodríguez-García C, Sánchez-Quesada C, Gaforio JJ. Dietary Flavonoids as Cancer Chemopreventive Agents: An Updated Review of Human Studies. Antioxidants 2019; 8(5): 137.[http://dx.doi.org/10.3390/antiox8050137] [PMID: 31109072][20]Abotaleb M, Samuel S, Varghese E, et al. Flavonoids in Cancer and Apoptosis. Cancers (Basel) 2018; 11(1): 28.[http://dx.doi.org/10.3390/cancers11010028] [PMID: 30597838][21]Neagu M, Constantin C, Popescu ID, et al. Inflammation and Metabolism in Cancer Cell—Mitochondria Key Player. Front Oncol 2019; 9: 348.[http://dx.doi.org/10.3389/fonc.2019.00348] [PMID: 31139559][22]Kopustinskiene DM, Jakstas V, Savickas A, Bernatoniene J. Flavonoids as Anticancer Agents. Nutrients 2020; 12(2): 457.[http://dx.doi.org/10.3390/nu12020457] [PMID: 32059369][23]Choi EJ, Jung JY, Kim GH. Genistein inhibits the proliferation and differentiation of MCF-7 and 3T3-L1 cells via the regulation of ERα expression and induction of apoptosis. Exp Ther Med 2014; 8(2): 454-8.[http://dx.doi.org/10.3892/etm.2014.1771] [PMID: 25009600][24]Solomon LA, Ali S, Banerjee S, Munkarah AR, Morris RT, Sarkar FH. Sensitization of ovarian cancer cells to cisplatin by genistein: the role of NF-kappaB. J Ovarian Res 2008; 1(1): 9.[http://dx.doi.org/10.1186/1757-2215-1-9] [PMID: 19025644][25]Shafiee G, Saidijam M, Tavilani H, Ghasemkhani N, Khodadadi I. Genistein Induces Apoptosis and Inhibits Proliferation of HT29 Colon Cancer Cells. Int J Mol Cell Med 2016; 5(3): 178-91.[PMID: 27942504][26]Park HJ, Jeon YK, You DH, Nam MJ. Daidzein causes cytochrome c-mediated apoptosis via the Bcl-2 family in human hepatic cancer cells. Food Chem Toxicol 2013; 60: 542-9.[http://dx.doi.org/10.1016/j.fct.2013.08.022] [PMID: 23959101][27]Merlin JPJ, Rupasinghe HPV, Dellaire G, Murphy K. Role of Dietary Antioxidants in p53-Mediated Cancer Chemoprevention and Tumor Suppression. Oxid Med Cell Longev 2021; 2021: 1-18.[http://dx.doi.org/10.1155/2021/9924328] [PMID: 34257824][28]Bao L, Liu F, Guo H, et al. Naringenin inhibits proliferation, migration, and invasion as well as induces apoptosis of gastric cancer SGC7901 cell line by downregulation of AKT pathway. Tumour Biol 2016; 37(8): 11365-74.[http://dx.doi.org/10.1007/s13277-016-5013-2] [PMID: 26960693][29]Zhang H, Zhong X, Zhang X, Shang D, Zhou Y, Zhang C. Enhanced anticancer effect of ABT-737 in combination with naringenin on gastric cancer cells. Exp Ther Med 2016; 11(2): 669-73.[http://dx.doi.org/10.3892/etm.2015.2912] [PMID: 26893664][30]Shiozaki EN, Shi Y. Caspases, IAPs and Smac/DIABLO: mechanisms from structural biology. Trends Biochem Sci 2004; 29(9): 486-94.[http://dx.doi.org/10.1016/j.tibs.2004.07.003] [PMID: 15337122][31]Du C, Fang M, Li Y, Li L, Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000; 102(1): 33-42.[http://dx.doi.org/10.1016/S0092-8674(00)00008-8] [PMID: 10929711][32]Moradzadeh M, Hosseini A, Erfanian S, Rezaei H. Epigallocatechin-3-gallate promotes apoptosis in human breast cancer T47D cells through down-regulation of PI3K/AKT and Telomerase. Pharmacol Rep 2017; 69(5): 924-8.[http://dx.doi.org/10.1016/j.pharep.2017.04.008] [PMID: 28646740][33]Luo H, Rankin GO, Li Z, DePriest L, Chen YC. Kaempferol induces apoptosis in ovarian cancer cells through activating p53 in the intrinsic pathway. Food Chem 2011; 128(2): 513-9.[http://dx.doi.org/10.1016/j.foodchem.2011.03.073] [PMID: 21625365][34]Ferdous UT, Yusof ZNB. Medicinal Prospects of Antioxidants From Algal Sources in Cancer Therapy. Front Pharmacol 2021; 12: 593116.[http://dx.doi.org/10.3389/fphar.2021.593116] [PMID: 33746748]

Medicinal Plants and Cancer Chemoprevention

J. Jothika1,J. Mohana Priya1,G. Rajapandeeswari1,M. Kalaimathi1,*
1 Karpagam Academy of Higher Education, Pollachi Main Road, Coimbatore-641021, India

Abstract

Cancer is identified as the second-most deadly disease all over the world. Various advancements have been made in the treatment of cancer to protect the life of human beings. However, the side effects may destroy the lives of the patients. Economically poor patients cannot afford the treatment, and they live short lives with cancer. So nowadays, research is going on to search for drugs without any side effects and that are cheap with good efficacy. Some medicinal plants have a lot of potential to act as anticancer agents but are not medically proven as discussed in this chapter. This review will focus on the various plant-derived chemical compounds that have shown anticancer activity.

Keywords: Anaferine, Anticancer activity, Annona Muricata L., Bullatacin, Camptotheca acuminata, Catharanthus roseus, Chemoprevention, Isopelletierine, Medicinal plants, Natural products.
*Corresponding author M. Kalaimathi: Karpagam Academy of Higher Education, Pollachi Main Road, Coimbatore-641021, India; E-mail: [email protected]

INTRODUCTION

Cells are the basic and small units involved in the construction of our body. The regular activity of a cell is to grow itself, and after sometime, it will fracture or break itself. This process is known as cell replication. When this regular activity becomes abnormal, it results in cancer. These types of abnormalities are inferred due to repaired DNA in the cells. There are many ways to affect the DNA of cells. Environmental activities can damage the cellular DNA. During cell growth and replication, there will be a chance to cumulate and form tumours. In this way, tumours degrade or damage the nearby healthy cells [1].

Cancer is considered the second-most deadly disease. The main reason for cellular DNA damage is lifestyle change, which is why researchers are focusing on finding new chemotherapeutic agents that are economically favourable to society. According to the survey report given by the WHO, in 2012, only 6 million people recovered from cancer out of 14 million. This is the financial barrier faced by the

affected people [2